APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Next Generation DNA Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Next Generation DNA Sequencing Market Outlook and Growth Opportunities 2026

Report ID 17419727044 March 2026198 pages

Choose your research edition.

Industry ResearchNext Generation DNA Sequencing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Next Generation DNA Sequencing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Next Generation DNA Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next Generation DNA Sequencing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Next Generation DNA Sequencing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Next Generation DNA Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Next Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Next Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Next Generation DNA Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Next Generation DNA Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Next Generation DNA Sequencing market include Quest Diagnostics Incorporated, ARUP Laboratories, Applied Biological Materials, Inc. (abm), Novogene Co, Ltd., Azenta Life Sciences (GENEWIZ), NanoString, Illumina, Inc., PacBio and Veritas, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Next Generation DNA Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Next Generation DNA Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Next Generation DNA Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Next Generation DNA Sequencing market.

Next Generation DNA Sequencing Segment by Company

Quest Diagnostics Incorporated

ARUP Laboratories

Applied Biological Materials, Inc. (abm)

Novogene Co, Ltd.

Azenta Life Sciences (GENEWIZ)

NanoString

Illumina, Inc.

PacBio

Veritas

BGI (Beijing Genomics Institute)

Gene by Gene Ltd.

Lucigen Corporation

Next Generation DNA Sequencing Segment by Type

Solexa Sequencing

454 Sequencing

Proton / PGM Sequencing

Next Generation DNA Sequencing Segment by Application

Universities & Other Research Entities

Hospitals & Clinics

Pharma & Biotech Entities

Others

Next Generation DNA Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Next Generation DNA Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Next Generation DNA Sequencing key companies, revenue, market share, and recent developments.

3. To split the Next Generation DNA Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Next Generation DNA Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Next Generation DNA Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Next Generation DNA Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation DNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next Generation DNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation DNA Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next Generation DNA Sequencing industry.

Chapter 3: Detailed analysis of Next Generation DNA Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Next Generation DNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Next Generation DNA Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Next Generation DNA Sequencing Industry Trends Table 2. Next Generation DNA Sequencing Industry Drivers Table 3. Next Generation DNA Sequencing Industry Opportunities and Challenges Table 4. Next Generation DNA Sequencing Industry Restraints Table 5. Global Next Generation DNA Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Next Generation DNA Sequencing Revenue Share by Company (2021-2026) Table 7. Global Next Generation DNA Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Next Generation DNA Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Next Generation DNA Sequencing Company, Product Type & Application Table 10. Global Next Generation DNA Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Next Generation DNA Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Solexa Sequencing Table 15. Significant Companies of 454 Sequencing Table 16. Significant Companies of Proton / PGM Sequencing Table 17. Global Next Generation DNA Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Next Generation DNA Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Next Generation DNA Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Next Generation DNA Sequencing Sales Value Share by Type (2021-2026) Table 21. Global Next Generation DNA Sequencing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Universities & Other Research Entities Table 23. Significant Companies of Hospitals & Clinics Table 24. Significant Companies of Pharma & Biotech Entities Table 25. Significant Companies of Others Table 26. Global Next Generation DNA Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Next Generation DNA Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Next Generation DNA Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Next Generation DNA Sequencing Sales Value Share by Application (2021-2026) Table 30. Global Next Generation DNA Sequencing Sales Value Share by Application (2027-2032) Table 31. Global Next Generation DNA Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Next Generation DNA Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Next Generation DNA Sequencing Sales Value Share by Region (2021-2026) Table 34. Global Next Generation DNA Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Next Generation DNA Sequencing Sales Value Share by Region (2027-2032) Table 36. Global Next Generation DNA Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Next Generation DNA Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Next Generation DNA Sequencing Sales Value Market Share by Country (2021-2026) Table 39. Global Next Generation DNA Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Next Generation DNA Sequencing Sales Value Market Share by Country (2027-2032) Table 41. Quest Diagnostics Incorporated Company Information Table 42. Quest Diagnostics Incorporated Business Overview Table 43. Quest Diagnostics Incorporated Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Quest Diagnostics Incorporated Next Generation DNA Sequencing Product Portfolio Table 45. Quest Diagnostics Incorporated Recent Development Table 46. ARUP Laboratories Company Information Table 47. ARUP Laboratories Business Overview Table 48. ARUP Laboratories Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. ARUP Laboratories Next Generation DNA Sequencing Product Portfolio Table 50. ARUP Laboratories Recent Development Table 51. Applied Biological Materials, Inc. (abm) Company Information Table 52. Applied Biological Materials, Inc. (abm) Business Overview Table 53. Applied Biological Materials, Inc. (abm) Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Applied Biological Materials, Inc. (abm) Next Generation DNA Sequencing Product Portfolio Table 55. Applied Biological Materials, Inc. (abm) Recent Development Table 56. Novogene Co, Ltd. Company Information Table 57. Novogene Co, Ltd. Business Overview Table 58. Novogene Co, Ltd. Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Novogene Co, Ltd. Next Generation DNA Sequencing Product Portfolio Table 60. Novogene Co, Ltd. Recent Development Table 61. Azenta Life Sciences (GENEWIZ) Company Information Table 62. Azenta Life Sciences (GENEWIZ) Business Overview Table 63. Azenta Life Sciences (GENEWIZ) Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Azenta Life Sciences (GENEWIZ) Next Generation DNA Sequencing Product Portfolio Table 65. Azenta Life Sciences (GENEWIZ) Recent Development Table 66. NanoString Company Information Table 67. NanoString Business Overview Table 68. NanoString Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. NanoString Next Generation DNA Sequencing Product Portfolio Table 70. NanoString Recent Development Table 71. Illumina, Inc. Company Information Table 72. Illumina, Inc. Business Overview Table 73. Illumina, Inc. Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Illumina, Inc. Next Generation DNA Sequencing Product Portfolio Table 75. Illumina, Inc. Recent Development Table 76. PacBio Company Information Table 77. PacBio Business Overview Table 78. PacBio Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. PacBio Next Generation DNA Sequencing Product Portfolio Table 80. PacBio Recent Development Table 81. Veritas Company Information Table 82. Veritas Business Overview Table 83. Veritas Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Veritas Next Generation DNA Sequencing Product Portfolio Table 85. Veritas Recent Development Table 86. BGI (Beijing Genomics Institute) Company Information Table 87. BGI (Beijing Genomics Institute) Business Overview Table 88. BGI (Beijing Genomics Institute) Next Generation DNA Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. BGI (Beijing Genomics Institute) Next Generation DNA Sequencing Product Portfolio Table 90. BGI (Beijing Genomics Institute) Recent Development Table 91. Gene by Gene Ltd. Company Information Table 92. Gene by Gene Ltd. Business Overview Table 93. Gene by Gene Ltd. Next Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Gene by Gene Ltd. Next Generation DNA Sequencing Product Portfolio Table 95. Gene by Gene Ltd. Recent Development Table 96. Lucigen Corporation Company Information Table 97. Lucigen Corporation Business Overview Table 98. Lucigen Corporation Next Generation DNA Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Lucigen Corporation Next Generation DNA Sequencing Product Portfolio Table 100. Lucigen Corporation Recent Development Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Next Generation DNA Sequencing Product Image Figure 2. Global Next Generation DNA Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next Generation DNA Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Next Generation DNA Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Solexa Sequencing Image Figure 8. 454 Sequencing Image Figure 9. Proton / PGM Sequencing Image Figure 10. Global Next Generation DNA Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Next Generation DNA Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Next Generation DNA Sequencing Sales Value Share by Type (2021-2032) Figure 13. Universities & Other Research Entities Image Figure 14. Hospitals & Clinics Image Figure 15. Pharma & Biotech Entities Image Figure 16. Others Image Figure 17. Global Next Generation DNA Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Next Generation DNA Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Next Generation DNA Sequencing Sales Value Share by Application (2021-2032) Figure 20. Global Next Generation DNA Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Next Generation DNA Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Next Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Next Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Next Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Next Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Next Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Next Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Next Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Next Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Next Generation DNA Sequencing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Next Generation DNA Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Solexa Sequencing
  • 454 Sequencing
  • Proton / PGM Sequencing
Applications
  • Universities & Other Research Entities
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others
Companies covered
  • Quest Diagnostics Incorporated
  • ARUP Laboratories
  • Applied Biological Materials, Inc. (abm)
  • Novogene Co, Ltd.
  • Azenta Life Sciences (GENEWIZ)
  • NanoString
  • Illumina, Inc.
  • PacBio
  • Veritas
  • BGI (Beijing Genomics Institute)
  • Gene by Gene Ltd.
  • Lucigen Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Next Generation DNA Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Next Generation DNA Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Next Generation DNA Sequencing Market Dynamics
  1. 2.1 Next Generation DNA Sequencing Industry Trends
  2. 2.2 Next Generation DNA Sequencing Industry Drivers
  3. 2.3 Next Generation DNA Sequencing Industry Opportunities and Challenges
  4. 2.4 Next Generation DNA Sequencing Industry Restraints
3 Next Generation DNA Sequencing Market by Company
  1. 3.1 Global Next Generation DNA Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Next Generation DNA Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Next Generation DNA Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Next Generation DNA Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Next Generation DNA Sequencing Company Product Type and Application
  6. 3.6 Global Next Generation DNA Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Next Generation DNA Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Next Generation DNA Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Next Generation DNA Sequencing Market by Type
  1. 4.1 Next Generation DNA Sequencing Type Introduction
  2. 4.1.1 Solexa Sequencing
  3. 4.1.2 454 Sequencing
  4. 4.1.3 Proton / PGM Sequencing
  5. 4.2 Global Next Generation DNA Sequencing Sales Value by Type
  6. 4.2.1 Global Next Generation DNA Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Next Generation DNA Sequencing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Next Generation DNA Sequencing Sales Value Share by Type (2021-2032)
5 Next Generation DNA Sequencing Market by Application
  1. 5.1 Next Generation DNA Sequencing Application Introduction
  2. 5.1.1 Universities & Other Research Entities
  3. 5.1.2 Hospitals & Clinics
  4. 5.1.3 Pharma & Biotech Entities
  5. 5.1.4 Others
  6. 5.2 Global Next Generation DNA Sequencing Sales Value by Application
  7. 5.2.1 Global Next Generation DNA Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Next Generation DNA Sequencing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Next Generation DNA Sequencing Sales Value Share by Application (2021-2032)
6 Next Generation DNA Sequencing Regional Value Analysis
  1. 6.1 Global Next Generation DNA Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Next Generation DNA Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Next Generation DNA Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Next Generation DNA Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Next Generation DNA Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Next Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Next Generation DNA Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Next Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Next Generation DNA Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Next Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Next Generation DNA Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Next Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Next Generation DNA Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Next Generation DNA Sequencing Sales Value Share by Country, 2025 VS 2032
7 Next Generation DNA Sequencing Country-level Value Analysis
  1. 7.1 Global Next Generation DNA Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Next Generation DNA Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Next Generation DNA Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Next Generation DNA Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Next Generation DNA Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Next Generation DNA Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Next Generation DNA Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics Incorporated
  2. 8.1.1 Quest Diagnostics Incorporated Company Information
  3. 8.1.2 Quest Diagnostics Incorporated Business Overview
  4. 8.1.3 Quest Diagnostics Incorporated Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Incorporated Next Generation DNA Sequencing Product Portfolio
  6. 8.1.5 Quest Diagnostics Incorporated Recent Developments
  7. 8.2 ARUP Laboratories
  8. 8.2.1 ARUP Laboratories Company Information
  9. 8.2.2 ARUP Laboratories Business Overview
  10. 8.2.3 ARUP Laboratories Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ARUP Laboratories Next Generation DNA Sequencing Product Portfolio
  12. 8.2.5 ARUP Laboratories Recent Developments
  13. 8.3 Applied Biological Materials, Inc. (abm)
  14. 8.3.1 Applied Biological Materials, Inc. (abm) Company Information
  15. 8.3.2 Applied Biological Materials, Inc. (abm) Business Overview
  16. 8.3.3 Applied Biological Materials, Inc. (abm) Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Applied Biological Materials, Inc. (abm) Next Generation DNA Sequencing Product Portfolio
  18. 8.3.5 Applied Biological Materials, Inc. (abm) Recent Developments
  19. 8.4 Novogene Co, Ltd.
  20. 8.4.1 Novogene Co, Ltd. Company Information
  21. 8.4.2 Novogene Co, Ltd. Business Overview
  22. 8.4.3 Novogene Co, Ltd. Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novogene Co, Ltd. Next Generation DNA Sequencing Product Portfolio
  24. 8.4.5 Novogene Co, Ltd. Recent Developments
  25. 8.5 Azenta Life Sciences (GENEWIZ)
  26. 8.5.1 Azenta Life Sciences (GENEWIZ) Company Information
  27. 8.5.2 Azenta Life Sciences (GENEWIZ) Business Overview
  28. 8.5.3 Azenta Life Sciences (GENEWIZ) Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Azenta Life Sciences (GENEWIZ) Next Generation DNA Sequencing Product Portfolio
  30. 8.5.5 Azenta Life Sciences (GENEWIZ) Recent Developments
  31. 8.6 NanoString
  32. 8.6.1 NanoString Company Information
  33. 8.6.2 NanoString Business Overview
  34. 8.6.3 NanoString Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NanoString Next Generation DNA Sequencing Product Portfolio
  36. 8.6.5 NanoString Recent Developments
  37. 8.7 Illumina, Inc.
  38. 8.7.1 Illumina, Inc. Company Information
  39. 8.7.2 Illumina, Inc. Business Overview
  40. 8.7.3 Illumina, Inc. Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Illumina, Inc. Next Generation DNA Sequencing Product Portfolio
  42. 8.7.5 Illumina, Inc. Recent Developments
  43. 8.8 PacBio
  44. 8.8.1 PacBio Company Information
  45. 8.8.2 PacBio Business Overview
  46. 8.8.3 PacBio Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PacBio Next Generation DNA Sequencing Product Portfolio
  48. 8.8.5 PacBio Recent Developments
  49. 8.9 Veritas
  50. 8.9.1 Veritas Company Information
  51. 8.9.2 Veritas Business Overview
  52. 8.9.3 Veritas Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Veritas Next Generation DNA Sequencing Product Portfolio
  54. 8.9.5 Veritas Recent Developments
  55. 8.10 BGI (Beijing Genomics Institute)
  56. 8.10.1 BGI (Beijing Genomics Institute) Company Information
  57. 8.10.2 BGI (Beijing Genomics Institute) Business Overview
  58. 8.10.3 BGI (Beijing Genomics Institute) Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BGI (Beijing Genomics Institute) Next Generation DNA Sequencing Product Portfolio
  60. 8.10.5 BGI (Beijing Genomics Institute) Recent Developments
  61. 8.11 Gene by Gene Ltd.
  62. 8.11.1 Gene by Gene Ltd. Company Information
  63. 8.11.2 Gene by Gene Ltd. Business Overview
  64. 8.11.3 Gene by Gene Ltd. Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Gene by Gene Ltd. Next Generation DNA Sequencing Product Portfolio
  66. 8.11.5 Gene by Gene Ltd. Recent Developments
  67. 8.12 Lucigen Corporation
  68. 8.12.1 Lucigen Corporation Company Information
  69. 8.12.2 Lucigen Corporation Business Overview
  70. 8.12.3 Lucigen Corporation Next Generation DNA Sequencing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lucigen Corporation Next Generation DNA Sequencing Product Portfolio
  72. 8.12.5 Lucigen Corporation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst